Blood-Brain Barrier in Cerebral Ischemia

脑缺血中的血脑屏障

基本信息

  • 批准号:
    6927112
  • 负责人:
  • 金额:
    $ 28.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-08-01 至 2007-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long term goal of this project is to identify blood-brain barrier (BBB) ion transporters that mediate ischemia induced brain edema, a major cause of brain damage in stroke. During the early hours of cerebral ischemia, brain edema formation occurs in the presence of an intact BBB. In this process, BBB endothelial cells transport Na and Cl from blood into brain interstitium, with osmotically obliged water following. The specific ion transporters responsible are unknown, however BBB luminal Na and Cl transporters appear to play a key role. Much evidence indicates that hypoxia, which rapidly develops during ischemia, aglycemia occurring as glucose is depleted, and also centrally-released vasopressin are mediators of ischemia-induced brain edema formation. A novel aspect of this proposed project is the preliminary finding that a Na-K-Cl cotransporter appears to be localized in the luminal membrane of brain microvessel endothelial cells and that vasopressin, hypoxia and aglycemia stimulate activity of the cotransporter. This has led to the central hypothesis that a Na-K-Cl cotransporter, located at the luminal membrane of the BBB, is stimulated during ischemia to increase transport of Na and Cl with osmotically obliged water from blood to brain, causing edema formation. The present project has three specific aims. The first aim is to test the hypothesis that Na-K-Cl cotransport is present in luminal membranes of cerebral microvascular endothelial cells (CMEC). These studies will evaluate bovine brain microvessel luminal and abluminal membrane preparations for cotransport activity by radioisotopic flux analyses. Also, the in situ distribution of the cotransporter will be examined by immunoelectron microscopy of brain sections. The second aim is to test the hypothesis that Na-K-CI cotransport of BBB endothelial cells is stimulated by agents that mediate ischemia-induced cerebral edema. Here, the effects of hypoxia, aglycemia and vasopressin on cotransport activity will be examined in cultured human and bovine CMEC and freshly isolated bovine cerebral microvessels. The third aim is to test the hypothesis that inhibition of Na-K-Cl cotransport activity attenuates ischemia-induced brain edema. To do this, the effect of inhibiting the cotransporter on ischemia-induced changes in rat brain Na and water will be examined by nuclear magnetic resonance methods, which allow in vivo changes in brain Na and water to be followed in real time. The proposed studies should reveal whether therapeutic approaches aimed at blocking BBB Na-K-Cl cotransporter activity may be of value for attenuating ischemia-induced brain edema.
描述(由申请人提供):该项目的长期目标是确定介导缺血引起的脑水肿的血脑屏障(BBB)离子转运体,这是中风脑损伤的主要原因。在脑缺血早期,脑水肿的形成是在血脑屏障完好的情况下发生的。在这一过程中,血脑屏障内皮细胞将Na和Cl从血液中转运到脑间质,随后是渗透吸收的水。具体的离子转运蛋白是未知的,然而血脑屏障内钠和氯转运蛋白似乎起着关键作用。大量证据表明,缺血期间迅速发生的缺氧、葡萄糖耗竭时发生的血糖以及中央释放的加压素是缺血诱导脑水肿形成的介质。这个项目的一个新颖方面是初步发现Na-K-Cl共转运蛋白似乎定位于脑微血管内皮细胞的管腔膜,并且加压素、缺氧和血糖刺激了共转运蛋白的活性。这导致了一个中心假设,即位于血脑屏障管腔膜的Na- k -Cl共转运体在缺血期间受到刺激,增加Na和Cl随渗透性水从血液到脑的运输,导致水肿形成。目前的项目有三个具体目标。第一个目的是验证脑微血管内皮细胞(CMEC)管腔膜中存在Na-K-Cl共转运的假设。这些研究将通过放射性同位素通量分析来评价牛脑微血管管腔和管腔膜制剂的共转运活性。此外,将通过脑切片的免疫电镜检查共转运体的原位分布。第二个目的是验证血脑屏障内皮细胞的Na-K-CI共运输被介导缺血诱导脑水肿的药物刺激的假设。本文将在培养的人和牛CMEC以及新鲜分离的牛大脑微血管中研究缺氧、血糖和加压素对共转运活性的影响。第三个目的是验证Na-K-Cl共转运活性的抑制可以减轻缺血性脑水肿的假设。为了做到这一点,抑制共转运体对缺血诱导的大鼠脑钠和水变化的影响将通过核磁共振方法进行检测,该方法可以实时跟踪体内脑钠和水的变化。拟议的研究应揭示旨在阻断血脑屏障Na-K-Cl共转运蛋白活性的治疗方法是否可能对减轻缺血诱导的脑水肿有价值。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Martha E O'Donnell其他文献

Regulation of ion pumps and carriers in vascular smooth muscle.
血管平滑肌中离子泵和载体的调节。
  • DOI:
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    33.6
  • 作者:
    Martha E O'Donnell;N. E. Owen
  • 通讯作者:
    N. E. Owen
Na-K-Cl cotransport in normal and glaucomatous human trabecular meshwork cells.
正常和青光眼人小梁网细胞中的 Na-K-Cl 共转运。

Martha E O'Donnell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Martha E O'Donnell', 18)}}的其他基金

2004 Barriers of CNS
2004 中枢神经系统障碍
  • 批准号:
    6836684
  • 财政年份:
    2004
  • 资助金额:
    $ 28.22万
  • 项目类别:
Blood-Brain Barrier in Cerebral Ischemia
脑缺血中的血脑屏障
  • 批准号:
    6548741
  • 财政年份:
    2002
  • 资助金额:
    $ 28.22万
  • 项目类别:
Blood-Brain Barrier in Cerebral Ischemia
脑缺血中的血脑屏障
  • 批准号:
    6630370
  • 财政年份:
    2002
  • 资助金额:
    $ 28.22万
  • 项目类别:
Blood-Brain Barrier Ion Transport in Cerebral Ischemia
脑缺血中的血脑屏障离子转运
  • 批准号:
    7871318
  • 财政年份:
    2002
  • 资助金额:
    $ 28.22万
  • 项目类别:
Blood-Brain Barrier Ion Transport in Cerebral Ischemia
脑缺血中的血脑屏障离子转运
  • 批准号:
    9059450
  • 财政年份:
    2002
  • 资助金额:
    $ 28.22万
  • 项目类别:
Blood-Brain-CSF Barriers, CNS Homeostasis, Drug Delivery
血脑脑脊液屏障、中枢神经系统稳态、药物输送
  • 批准号:
    6550284
  • 财政年份:
    2002
  • 资助金额:
    $ 28.22万
  • 项目类别:
Blood-Brain Barrier Ion Transport in Cerebral Ischemia
脑缺血中的血脑屏障离子转运
  • 批准号:
    8720068
  • 财政年份:
    2002
  • 资助金额:
    $ 28.22万
  • 项目类别:
Blood-Brain Barrier Ion Transport in Cerebral Ischemia
脑缺血中的血脑屏障离子转运
  • 批准号:
    7526441
  • 财政年份:
    2002
  • 资助金额:
    $ 28.22万
  • 项目类别:
Blood-Brain Barrier Ion Transport in Cerebral Ischemia
脑缺血中的血脑屏障离子转运
  • 批准号:
    8870444
  • 财政年份:
    2002
  • 资助金额:
    $ 28.22万
  • 项目类别:
Blood-Brain Barrier in Cerebral Ischemia
脑缺血中的血脑屏障
  • 批准号:
    6773194
  • 财政年份:
    2002
  • 资助金额:
    $ 28.22万
  • 项目类别:

相似海外基金

ICF: Enhancing Blood-Brain Barrier Opening with Ultrasound and Microwaves for Targeted Drug Delivery
ICF:利用超声波和微波增强血脑屏障开放以实现靶向药物输送
  • 批准号:
    MR/Z503848/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.22万
  • 项目类别:
    Research Grant
Venom-derived blood-brain-barrier shuttles
毒液衍生的血脑屏障穿梭机
  • 批准号:
    DP230102707
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
    Discovery Projects
Development of blood-brain barrier-penetrating oligosaccharides
穿透血脑屏障寡糖的开发
  • 批准号:
    23K11852
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Defining mechanisms of blood-brain barrier dysfunction in cerebral small vessel disease using advanced 3D in vitro models.
使用先进的 3D 体外模型定义脑小血管疾病血脑屏障功能障碍的机制。
  • 批准号:
    MR/W027119/1
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
    Fellowship
Understanding suppression of transcytosis in formation of the blood-brain barrier (BBB) and how Calcrl/Ramp2 signalling limits BBB permeability
了解血脑屏障 (BBB) 形成过程中转胞吞作用的抑制以及 Calcrl/Ramp2 信号如何限制 BBB 通透性
  • 批准号:
    MR/X008215/1
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
    Research Grant
The blood-brain barrier and Alzheimer pathology
血脑屏障和阿尔茨海默病病理学
  • 批准号:
    10800246
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
Bisphenol-Induced Blood-Brain Barrier Dysfunction in Alzheimer’s Disease
双酚引起的阿尔茨海默氏病血脑屏障功能障碍
  • 批准号:
    10713025
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
Circadian Rhythms in Blood Brain Barrier Permeability and Increased Efficacy of Chemotherapy for Brain Metastases
血脑屏障通透性的昼夜节律和脑转移化疗疗效的提高
  • 批准号:
    10663717
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
Blood brain barrier integrity and immune dynamics contributing to neuropsychiatric sequela in COVID long-haulers
血脑屏障完整性和免疫动态导致新冠长途运输者的神经精神后遗症
  • 批准号:
    10688300
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
MicroRNAs, Mitochondria and the Blood-Brain Barrier - Therapeutic Targets for Stroke
MicroRNA、线粒体和血脑屏障——中风的治疗靶点
  • 批准号:
    10587899
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了